Circular
No. 19/2001-CUS Dated 23.3.2001
Export of sub-standard drugs by various
companies and claiming DEPB/Drawback benefits thereon.
DRI
has issued an alert Circular No.12/2001 from F.No.50D/9/2001-CI dated 9.2.2001
on the above subject whereas it appears that
certain lesser known companies are attempting to export sub-standard
formulations, which do not conform to the composition declared on the
containers/labels, and may be of little therapeutical value and may not conform
to pharmacoepea; these drugs are attempted to be exported under various export
promotion schemes.
2.
In such cases, it appears that actual composition of drugs exported is different
from the composition given on the containers/labels, and thus would constitute
mis-declaration. Such cases fall under the category of mis-declaration under
various provisions of Customs Act, which would be attracted in such cases. In
view thereof, apart from necessary
action under the Customs Act, such exports would not be eligible to the benefits
under various export promotion schemes which are otherwise available for export
of certain standard formulations assuming certain percentages of active
ingredients imparting therapeutical properties etc.
3. Contents of this Circular may be brought to the notice of the concerned officers and a watch be kept to ensure that attempt is not made to get away with unwarranted export benefits by misdeclaring nature & compost of Drugs/formulations.
Sd/-
(R.K.Talajia)
Senior Technical Officer (DBK)